Serum BLyS levels increase after rituximab as initial therapy in patients with follicular grade 1 non-Hodgkin lymphoma

Stephen M. Ansell, Anne J. Novak, Steven Ziesmer, Tammy Price-Troska, Betsy Laplant, Stacey R. Dillon, Thomas E. Witzig

Research output: Contribution to journalArticle

15 Scopus citations

Fingerprint Dive into the research topics of 'Serum BLyS levels increase after rituximab as initial therapy in patients with follicular grade 1 non-Hodgkin lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences